期刊文献+

氯胺酮相关性泌尿系统损害56例分析 被引量:2

Analysis on 56 Cases of Ketamine-associated Urinary System Dysfunction
下载PDF
导出
摘要 目的:探讨滥用氯胺酮所引起的泌尿系统损害及诊治方法。方法:回顾性分析56例有滥用氯胺酮史患者的泌尿系统症状、体征、泌尿系统相关检查,根据不同情况予以相关治疗方案的探讨。结果:氯胺酮相关性泌尿系统损害主要症状为下尿路症状(LUTS),膀胱病理活检表现为不同程度的炎症改变。影像学检查可见不同程度的病变,主要表现为:膀胱容量小,膀胱壁增厚,膀胱挛缩,输尿管狭窄,肾积水。3例患者血清肌酐升高。结论:氯胺酮相关性泌尿系统损害是以下尿路症状(LUTS)为主要临床表现的疾病,疾病早期为可逆性,治疗效果良好,后期继发的膀胱挛缩和肾功能损害是不可逆的,需要引起重视。 To explore the diagnosis and treatment of ketamine-associated urinary system dysfunction. Methods. Totally 56 cases of urinary tract symptoms with the history of ketamine abuse in recent years were retrospectively analyzed. The routine examination and the examination related to the urinary system were given, and individual treatment was undertaken according to different situation. Results: The main symptom of ketamineasscociated urinary tract dysfunction was lower urinary tract symptom (LUTS). Bladder pathologic biopsy showed different degree of inflammatory change. Imaging examination showed various degree of pathological changes, including reduced bladder capacity, thickened bladder wall, bladder contracture, ureteral stricture and hydronephrosis. Three patients had increased serum creatinine level. Conclusion: Ketamine-asscociated urinary system dysfunction is a disease with LUTS as the main clinical symptom. At the early stage, the disease is reversible with promising treatment outcome. In the progression of the disease, some patients develop irreversible histological changes in the urinary tract, which should be brought to the forefront.
出处 《中国药师》 CAS 2014年第5期831-833,共3页 China Pharmacist
关键词 氯胺酮 药物滥用 泌尿系统损害 Ketamine Drug abuse Urinary system dysfunction
  • 相关文献

参考文献9

  • 1Parsons CL,Dell J,Stanford E J,et al.Increased prevalence of inter-stitial cystitis:previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassi-um sensitivity[J].Urology,2002,60(4):573-578.
  • 2Shahani R,Streutker C,Dickson B,et al.Ketamine-associated ulcer-ative cystitis:a new clinical entity[J].Urology,2007,69(5):810-812.
  • 3Garcta-Larmsa A,Castillo C,Ventura M,et al.Cystitis and ket-amine associated bladder dysfunction [ J ].Actas Urol Esp,2012,36(1):60-64.
  • 4Ho CC,Pezhman H,Praveen S,et al.Ketamine-Associated Ulcera-tive Cystitis:A Case Report and Literature Review [ J ].Malays J Med Sci,2010,17(2):61-65.
  • 5Middela S,Pearce I.Ketamine-induced vesicopathy:a literature re-view[ J].Int J Clin Pract,2011,65(1):27-30.
  • 6Chu PS,Ma WK,Wang SC,et al.The destruction of the lower uri-nary tract by ketamine abuse:a new syndrome? [ J ].BJU Int,2008,102(11):1616-1622.
  • 7Phull H,Salkini M,Purves T.Angiotensin Ⅱ plays a role in acute murine experimental autoimmune cystitis [ J].BJU Int,2007;100(3):664-667.
  • 8郭炬,魏卓,梁铸林,蒋国松,罗兵锋,曾甫清.氯胺酮相关性膀胱功能障碍(附8例报告)[J].临床泌尿外科杂志,2011,26(1):39-40. 被引量:4
  • 9方烈奎,张泽键,杨江根,张轶庠.乙状结肠膀胱扩大成形术治疗氯胺酮所致膀胱挛缩[J].中华泌尿外科杂志,2010,31(7):471-474. 被引量:29

二级参考文献15

  • 1Chu PS,Kwok SC,Lam KM,et al.Street ketamine-associated bladder dysfunction:a reprort of ten cases.Hong Kong Med J,2007,13:311-313.
  • 2Shahani R,Streutker C,Dickson B,et al.Ketamine-associated ulcerative cystitis:a new clinical entity.Urology,2007,69:810-812.
  • 3Tsai TH,Cha TL,Lin CM,et al.Ketamine-associated bladder dysfunction.Int J Urol,2009,16:826-829.
  • 4Chu PS,Ma WK,Wong SC.et al.The destruction of the lower urinary tract by ketamine abuse:a new syndrome?BJU Int,2008,102:1616-1622.
  • 5Flood HD,Ritchey ML,Blood DA,et al.outcome of reflux in children with myelodysplasia managed by bladder pressure monitoring.J Urol,1994,152:1574-1577.
  • 6Shekarriz B,Upadhyay J.Demirbilek S,et al.Surgical complications of bladder augmentation:comparison between various enterocystoplasties in 133 patients.Uology,2000,55:123-128.
  • 7Sheiner JR,Kaplan GW.Spontaneous bladder rupture following enterocystoplasty.J Urol,1988,140:1157-1158.
  • 8Elder JS,Snyder HM.Hulbert WC,et al.Perforation of the augmented bladder in patients underdoing clean intermittent catheterization.J Urol,1988,140:1159-1162.
  • 9Shahani R,Streutker C,Dickson B.Ketamine-associated ulcerative cystitis:a new clinical entity[J].Urology,2007,69(5):810-812.
  • 10Moore K A,Sklerov J,Levine B,et al.Urine concentrations of ketamine and norketamine following illegal consumption[J].J Anal Toxicol,2001,25(7):583-588.

共引文献28

同被引文献54

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部